![Shipra Gandhi: How a novel strategy can modulate the chemokine milieu in the TME](https://oncodaily.com/pub/uploads/2023/11/111111-1-e1700682536159.jpeg)
Photo of Shipra Gandhi from medicine.buffalo.edu
Nov 22, 2023, 16:06
Shipra Gandhi: How a novel strategy can modulate the chemokine milieu in the TME
Shipra Gandhi, Translational Researcher at Roswell Park Comprehensive Cancer Center, shared a post by Journal for ImmunoTherapy of Cancer on X/Twitter, adding:
”We are excited to share our findings from a clinical trial in TNBC showing how a novel strategy can modulate the chemokine milieu in the TME.”
Quoting Journal for ImmunoTherapy of Cancer‘s post:
”New JITC article: Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor micro environments for selective CTL influx.”
For the article click here.
Source: Shipra Gandhi/Twitter and Journal for ImmunoTherapy of Cancer/Twitter